NH · State regulatory reference
New Hampshire.
Moderate
New Hampshire's telemedicine practice of medicine is governed by RSA 329:1-d (amended 2025), which permits diagnosis, consultation, and treatment via synchronous or asynchronous electronic media once a physician-patient relationship is established, under the same standard of care as in-person. Compounding under Board of Pharmacy rule Ph 404 requires compliance with current USP including <795> and <797> — a standard 503A framework with no distinctive GLP-1/semaglutide restriction. No NH-specific board enforcement was found in primary sources.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
RSA 329:1-d allows an initial visit and prescribing via synchronous audio-video once a physician-patient relationship is established; for Schedule II-IV controlled drugs prescribed by telemedicine a subsequent in-person exam is required, with follow-up not less than annually.
Compounding
Board of Pharmacy rule Ph 404.01 requires compounders to adhere to current USP including <795> and <797>; there is no NH-specific GLP-1 or semaglutide restriction beyond federal 503A.
Sources